Development Level

Tbio 5 | 10,625
Tdark 1 | 7,003

IMPC Term

embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
preweaning lethality, complete... 1 | 633

Disease

Complement deficiency 3 | 15
Kidney disease 3 | 396
Vascular disease 3 | 281
ovarian cancer 3 | 8,484
systemic lupus erythematosus 3 | 156
Anemia 2 | 252
Arthritis 2 | 248
Cancer 2 | 2,346
Congenital adrenal hyperplasia 2 | 74
Felty's syndrome 2 | 7
Immunoglobulin alpha deficiency 2 | 10
Malaria 2 | 140
Rheumatoid Arthritis 2 | 1,160
Type 1 diabetes mellitus 2 | 101
Waldenstrons macroglobulinemia 2 | 765
chronic lymphosyte leukemia 2 | 232
interstitial cystitis 2 | 2,299
lung cancer 2 | 4,466
mucosa-associated lymphoid tissue lymphoma 2 | 480
primary Sjogren syndrome 2 | 789
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Allergic conjunctivitis 1 | 25
Allergic hypersensitivity disease 1 | 123
Alzheimer's disease 1 | 644
Asthma 1 | 349
Autistic Disorder 1 | 320
Autoimmune Diseases 1 | 33
Carcinoma 1 | 2,147
Cervical dystonia 1 | 9
Collagen disease 1 | 25
Congenital afibrinogenemia 1 | 9
Dengue disease 1 | 19
Drug Eruptions 1 | 18
Encephalitis 1 | 54
Gout 1 | 93
Hepatitis B 1 | 103
Herpangina 1 | 9
Human immunodeficiency virus infectious disease 1 | 92
Hypersensitivity reaction type II disease 1 | 235
Hyperthyroidism 1 | 50
Hypothyroidism 1 | 89
IGA Glomerulonephritis 1 | 454
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Keratoconjunctivitis sicca 1 | 19
Leptospirosis 1 | 17
Leukemia, Myelocytic, Acute 1 | 113
Lung disease 1 | 132
Lupus erythematosus 1 | 80
Lyme disease 1 | 23
Malaria, Falciparum 1 | 3
Mouth disease 1 | 6
Multiple Sclerosis 1 | 498
Multiple myeloma 1 | 1,327
Nephritis 1 | 29
Neuromyelitis optica 1 | 20
Neuropathy 1 | 210
Protein S deficiency 1 | 5
Relapsing fever 1 | 16
Skin disease 1 | 65
Smallpox 1 | 20
Syphilis 1 | 18
Tetanus 1 | 66
Thrombocytopenia 1 | 105
Thyroiditis 1 | 25
Tularemia 1 | 22
axial spondyloarthropathy 1 | 28
cutaneous lupus erythematosus 1 | 1,056
cystic fibrosis 1 | 1,665
diabetes mellitus 1 | 1,663
group 3 medulloblastoma 1 | 2,254
hand, foot and mouth disease 1 | 11
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hemolytic-uremic syndrome 1 | 28
hepatocellular carcinoma 1 | 532
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
nasopharyngeal carcinoma 1 | 1,056
non primary Sjogren syndrome sicca 1 | 840
non-small cell lung cancer 1 | 2,798
osteosarcoma 1 | 7,933
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
psoriasis 1 | 6,685
sarcoidosis 1 | 358
subependymal giant cell astrocytoma 1 | 2,287

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 5 | 11,971
Enzyme 1 | 4,146

Grant Application

7R01AI054544-04 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Complement receptor type 1 CR1 Tbio Non-IDG -3.33619 2279.9 502
Probable ATP-dependent RNA helicase DDX41 DDX41 Tbio Enzyme -3.57193 3737.6 208
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Complement C4-B C4B Tbio Non-IDG -2.98908 993.5 152
Complement C4-A C4B Tbio Non-IDG -3.03903 1088.3 292
DNL-type zinc finger protein DNLZ Tdark Non-IDG -0.95825 9.83 0